Lecault Veronique
- SEC CIK
- 0001834418
No open-market purchases or sales filed in the past year.
Current role at each company
- ABCL AbCellera Biologics Inc.Chief Technology Officeras of Jan 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lecault Veronique as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 12 | 2 days | Lecault VeroniqueChief Operating Officer | PPurchase | +20.0K | $5.19 | +$103.8K | +1.0%2.04M after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Lecault VeroniqueChief Operating Officer | PPurchase | +200.0K | $6.34 | +$1.27M | +12.7%1.77M after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Lecault VeroniqueChief Operating Officer | PPurchase | +230.8K | $8.66 | +$2.00M | +17.2%1.57M after |